125 related articles for article (PubMed ID: 37218946)
1. Applying a Radiation Therapy Volume Analysis Pipeline to Determine the Utility of Spectroscopic MRI-Guided Adaptive Radiation Therapy for Glioblastoma.
Trivedi AG; Kim SH; Ramesh KK; Giuffrida AS; Weinberg BD; Mellon EA; Kleinberg LR; Barker PB; Han H; Shu HG; Shim H; Schreibmann E
Tomography; 2023 May; 9(3):1052-1061. PubMed ID: 37218946
[TBL] [Abstract][Full Text] [Related]
2. 3-Dimensional magnetic resonance spectroscopic imaging at 3 Tesla for early response assessment of glioblastoma patients during external beam radiation therapy.
Muruganandham M; Clerkin PP; Smith BJ; Anderson CM; Morris A; Capizzano AA; Magnotta V; McGuire SM; Smith MC; Bayouth JE; Buatti JM
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):181-9. PubMed ID: 24986746
[TBL] [Abstract][Full Text] [Related]
3. The Brain Imaging Collaboration Suite (BrICS): A Cloud Platform for Integrating Whole-Brain Spectroscopic MRI into the Radiation Therapy Planning Workflow.
Gurbani S; Weinberg B; Cooper L; Mellon E; Schreibmann E; Sheriff S; Maudsley A; Goryawala M; Shu HK; Shim H
Tomography; 2019 Mar; 5(1):184-191. PubMed ID: 30854456
[TBL] [Abstract][Full Text] [Related]
4. Spectroscopic MRI-Based Biomarkers Predict Survival for Newly Diagnosed Glioblastoma in a Clinical Trial.
Trivedi AG; Ramesh KK; Huang V; Mellon EA; Barker PB; Kleinberg LR; Weinberg BD; Shu HG; Shim H
Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444634
[TBL] [Abstract][Full Text] [Related]
5. Simulating the Effect of Spectroscopic MRI as a Metric for Radiation Therapy Planning in Patients with Glioblastoma.
Cordova JS; Kandula S; Gurbani S; Zhong J; Tejani M; Kayode O; Patel K; Prabhu R; Schreibmann E; Crocker I; Holder CA; Shim H; Shu HK
Tomography; 2016 Dec; 2(4):366-373. PubMed ID: 28105468
[TBL] [Abstract][Full Text] [Related]
6. Patterns of recurrence analysis in newly diagnosed glioblastoma multiforme after three-dimensional conformal radiation therapy with respect to pre-radiation therapy magnetic resonance spectroscopic findings.
Park I; Tamai G; Lee MC; Chuang CF; Chang SM; Berger MS; Nelson SJ; Pirzkall A
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):381-9. PubMed ID: 17513061
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme.
Deviers A; Ken S; Filleron T; Rowland B; Laruelo A; Catalaa I; Lubrano V; Celsis P; Berry I; Mogicato G; Cohen-Jonathan Moyal E; Laprie A
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):385-93. PubMed ID: 25104068
[TBL] [Abstract][Full Text] [Related]
8. Whole-brain spectroscopic MRI biomarkers identify infiltrating margins in glioblastoma patients.
Cordova JS; Shu HK; Liang Z; Gurbani SS; Cooper LA; Holder CA; Olson JJ; Kairdolf B; Schreibmann E; Neill SG; Hadjipanayis CG; Shim H
Neuro Oncol; 2016 Aug; 18(8):1180-9. PubMed ID: 26984746
[TBL] [Abstract][Full Text] [Related]
9. Distinguishing Tumor Recurrence From Radiation Necrosis in Treated Glioblastoma Using Multiparametric MRI.
Feng A; Yuan P; Huang T; Li L; Lyu J
Acad Radiol; 2022 Sep; 29(9):1320-1331. PubMed ID: 34896001
[TBL] [Abstract][Full Text] [Related]
10. Early Metabolic Changes in 1H-MRSI Predictive for Survival in Patients With Newly Diagnosed High-grade Glioma.
Wang MH; Roa W; Wachowicz K; Yahya A; Murtha A; Amanie J; Chainey J; Quon H; Ghosh S; Patel S
Anticancer Res; 2022 May; 42(5):2665-2673. PubMed ID: 35489774
[TBL] [Abstract][Full Text] [Related]
11. Association of Radiomics and Metabolic Tumor Volumes in Radiation Treatment of Glioblastoma Multiforme.
Lopez CJ; Nagornaya N; Parra NA; Kwon D; Ishkanian F; Markoe AM; Maudsley A; Stoyanova R
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):586-595. PubMed ID: 28011044
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric MR Imaging of Diffusion and Perfusion in Contrast-enhancing and Nonenhancing Components in Patients with Glioblastoma.
Boonzaier NR; Larkin TJ; Matys T; van der Hoorn A; Yan JL; Price SJ
Radiology; 2017 Jul; 284(1):180-190. PubMed ID: 28240563
[TBL] [Abstract][Full Text] [Related]
13. Spectroscopic MRI-Guided Proton Therapy in Non-Enhancing Pediatric High-Grade Glioma.
Huang V; Rejimon A; Reddy K; Trivedi AG; Ramesh KK; Giuffrida AS; Muiruri R; Shim H; Eaton BR
Tomography; 2023 Mar; 9(2):633-646. PubMed ID: 36961010
[TBL] [Abstract][Full Text] [Related]
14. Developing a Pipeline for Multiparametric MRI-Guided Radiation Therapy: Initial Results from a Phase II Clinical Trial in Newly Diagnosed Glioblastoma.
Kim MM; Parmar HA; Aryal MP; Mayo CS; Balter JM; Lawrence TS; Cao Y
Tomography; 2019 Mar; 5(1):118-126. PubMed ID: 30854449
[TBL] [Abstract][Full Text] [Related]
15. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
16. Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1).
Oehlke O; Mix M; Graf E; Schimek-Jasch T; Nestle U; Götz I; Schneider-Fuchs S; Weyerbrock A; Mader I; Baumert BG; Short SC; Meyer PT; Weber WA; Grosu AL
BMC Cancer; 2016 Oct; 16(1):769. PubMed ID: 27716184
[TBL] [Abstract][Full Text] [Related]
17. Volumetric spectroscopic imaging of glioblastoma multiforme radiation treatment volumes.
Parra NA; Maudsley AA; Gupta RK; Ishkanian F; Huang K; Walker GR; Padgett K; Roy B; Panoff J; Markoe A; Stoyanova R
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):376-84. PubMed ID: 25066215
[TBL] [Abstract][Full Text] [Related]
18. PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator.
Bolcaen J; Descamps B; Boterberg T; Vanhove C; Goethals I
J Vis Exp; 2017 Dec; (130):. PubMed ID: 29364211
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677.
Ratai EM; Zhang Z; Snyder BS; Boxerman JL; Safriel Y; McKinstry RC; Bokstein F; Gilbert MR; Sorensen AG; Barboriak DP
Neuro Oncol; 2013 Jul; 15(7):936-44. PubMed ID: 23645534
[TBL] [Abstract][Full Text] [Related]
20. Association of early changes in 1H MRSI parameters with survival for patients with newly diagnosed glioblastoma receiving a multimodality treatment regimen.
Nelson SJ; Kadambi AK; Park I; Li Y; Crane J; Olson M; Molinaro A; Roy R; Butowski N; Cha S; Chang S
Neuro Oncol; 2017 Mar; 19(3):430-439. PubMed ID: 27576874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
